UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes.

  • Journal Article

Nature microbiology, Volume: 1
September 19, 2016
Michelle Yi-Xiu Lim MY, Gregory LaMonte G, Marcus C S Lee MCS, Christin Reimer C, Bee Huat Tan BH, Victoria Corey V, Bianca F Tjahjadi BF, Adeline Chua A, Marie Nachon M, René Wintjens R, Peter Gedeck P, Benoit Malleret B, Laurent Renia L, Ghislain M C Bonamy GMC, Paul Chi-Lui Ho PC, Bryan K S Yeung BKS, Eric D Chow ED, Liting Lim L, David A Fidock DA, Thierry T Diagana TT, Elizabeth A Winzeler EA, Pablo Bifani P

A molecular understanding of drug resistance mechanisms enables surveillance of the effectiveness of new antimicrobial therapies during development and deployment in the field. We used conventional drug resistance selection as well as a regime of limiting dilution at early stages of drug treatment to probe two antimalarial imidazolopiperazines, KAF156 and GNF179. The latter approach permits the isolation of low-fitness mutants that might otherwise be out-competed during selection. Whole-genome sequencing of 24 independently derived resistant Plasmodium falciparum clones revealed four parasites with mutations in the known cyclic amine resistance locus (pfcarl) and a further 20 with mutations in two previously unreported P. falciparum drug resistance genes, an acetyl-CoA transporter (pfact) and a UDP-galactose transporter (pfugt). Mutations were validated both in vitro by CRISPR editing in P. falciparum and in vivo by evolution of resistant Plasmodium berghei mutants. Both PfACT and PfUGT were localized to the endoplasmic reticulum by fluorescence microscopy. As mutations in pfact and pfugt conveyed resistance against additional unrelated chemical scaffolds, these genes are probably involved in broad mechanisms of antimalarial drug resistance.

Courtesy of the U.S. National Library of Medicine